Momenta is a biotechnology company that discovers, develops and commercializes novel therapeutics for the treatment of immune-mediated diseases.
Business Model:
Revenue: $30M
Employees: 51-200
Momenta Pharmaceuticals, Inc. was acquired by
Johnson &a; Johnson.
The acquisition happend on 2020-08-19.
Details of the transaction were not public
Address: 301 Binney Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Momenta is a biotechnology company that discovers, develops and commercializes novel therapeutics for the treatment of immune-mediated diseases.
Contact Phone:
+16174919700
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/2/2004
Ticker Symbol:
MNTA
IPO Price:
$6.5/share
Amount Raised:
$35M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2004 | Series C | $20.5M | 6/2004 | IPO | $34.8M | 3/2004 | Series C | 5 | $20.5M |
Atlas Venture Mithra Ventures Cardinal Partners MVM Life Science Partners Polaris Ventures Mithra Ventures Atlas Venture Mithra Ventures Cardinal Partners MVM Life Science Partners Polaris Ventures Mithra Ventures |
5/2003 | Series B | 4 | $19M |
Polaris Ventures Atlas Venture MVM Life Science Partners Cardinal Partners Atlas Venture MVM Life Science Partners Polaris Ventures Atlas Venture MVM Life Science Partners Cardinal Partners Atlas Venture MVM Life Science Partners |
---|
Announced Date | Name | Price |
---|---|---|
12/2011 | Virdante Pharmaceuticals | |
5/2007 | Parivid |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|